Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
NCT05806554 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159
Last updated 2025-11-25
Summary
The purpose of the investigation is to evaluate the performance of the I3 CGM according to the FDA's special controls for iCGM.
Conditions
Interventions
- DEVICE
-
Continuous glucose monitoring device
Continuous glucose monitoring device
Sponsors & Collaborators
-
Integrated Medical Development
collaborator INDUSTRY -
Sinocare
lead INDUSTRY
Principal Investigators
-
Ron Brazg, MD · RCRC
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-19
- Primary Completion
- 2024-06-13
- Completion
- 2024-10-22
- FDA Device
- Yes
Countries
- United States
- Germany
Study Locations
More Related Trials
-
Effect of CGM on Glucose Control in Non-insulin-treated Patients with Type 2 Diabetes Mellitus
NCT06587438 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluate the Safety and Efficacy of Sinocare CGM System Regarding Real Time Glucose Level Monitoring
NCT05995756 ·Status: COMPLETED
-
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study
NCT04464772 ·Status: COMPLETED
-
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
NCT01831752 ·Status: COMPLETED
-
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
NCT05944432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period
NCT06904846 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
NCT03730480 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
NCT01341067 ·Status: COMPLETED
-
A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes
NCT00674986 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System
NCT02073058 ·Status: COMPLETED
-
FreeStyle Libre 3 Continuous Glucose Monitoring System
NCT05962710 ·Status: TERMINATED
-
Continuous Glucose Monitoring System Use in Pediatric Patients with Diabetes
NCT06570551 ·Status: COMPLETED
-
Accuracy Characterization Study
NCT01932944 ·Status: COMPLETED
-
Comparison Evaluation of Blood Glucose Meter Systems
NCT01548885 ·Status: COMPLETED ·Phase: NA
-
A Pilot Trial of the Non-invasive H.G.R Glucometer
NCT04658082 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
NCT07092761 ·Status: RECRUITING ·Phase: NA
-
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
NCT01745900 ·Status: UNKNOWN
-
User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013
NCT03033849 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
NCT04645641 ·Status: UNKNOWN ·Phase: NA
-
Study of an Interstitial Fluid Glucose Sensor
NCT05251116 ·Status: COMPLETED ·Phase: NA
-
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
NCT00465881 ·Status: COMPLETED
-
FreeStyle Libre Flash Glucose Monitoring System Accuracy
NCT03159546 ·Status: COMPLETED
-
Freestyle Libre Flash Glucose Monitoring System
NCT03607448 ·Status: COMPLETED
-
Continuous Glucose Monitoring System in Intensive Care Unit
NCT01995994 ·Status: COMPLETED
-
FreeStyle Libre Flash Glucose Monitoring System Accuracy Study
NCT03141892 ·Status: COMPLETED